Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FAME 1 Eye
2019-002591-14Phase 3Unknown
- Sponsor
- Belfast Health and Social Care Trust
- Start
- Sep 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in diabetic retinopathy (DR) and diabetes mellitus type 1 (T1D) comparing Fenofibrate with Placebo (2 arms). Primary endpoint: Clinically significant retinopathy progression. Status: unknown.
02
Drugs
fenofibrate
03
Conditions
diabetic retinopathy (DR)diabetes mellitus type 1 (T1D)
Beyond the preview
Go deeper on 2019-002591-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-002591-14.